A Phase I/IIa Study investigating the safety and tolerability of intramuscular DVC1-0101 compared with placebo in patients with Intermittent Claudication or Critical Limb Ischaemia Secondary to Peripheral Artery Disease.

Trial Profile

A Phase I/IIa Study investigating the safety and tolerability of intramuscular DVC1-0101 compared with placebo in patients with Intermittent Claudication or Critical Limb Ischaemia Secondary to Peripheral Artery Disease.

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 01 Apr 2017

At a glance

  • Drugs DVC1 0101 (Primary)
  • Indications Intermittent claudication; Peripheral ischaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 31 Mar 2017 Status changed from not yet recruiting to recruiting.
    • 24 Aug 2016 Planned initiation date changed from 1 Aug 2016 to 1 Sep 2016.
    • 13 Jul 2016 Planned initiation date changed from 14 Oct 2015 to 1 Aug 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top